Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Ordinary Shares, nominal value 0.05 GBP per share
-
Shares outstanding
-
84,213,667
-
Total 13F shares
-
34,799,135
-
Share change
-
-1,644,733
-
Total reported value
-
$145,683,724
-
Price per share
-
$4.19
-
Number of holders
-
36
-
Value change
-
-$8,606,491
-
Number of buys
-
12
-
Number of sells
-
12
Institutional Holders of Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) as of Q2 2022
As of 30 Jun 2022 Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) had 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 34,799,135 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, NEA Management Company, LLC, RA CAPITAL MANAGEMENT, L.P., WELLINGTON MANAGEMENT GROUP LLP, PERCEPTIVE ADVISORS LLC, Vivo Capital, LLC, Abingworth LLP, Aisling Capital Management LP, Foresite Capital Management III, LLC, and Samsara BioCapital, LLC.
This table shows 36 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.